Exploration of a screening model for intrahepatic cholangiocarcinoma patients prone to cuproptosis and mechanisms of the susceptibility of CD274-knockdown intrahepatic cholangiocarcinoma cells to cuproptosis

EREG is the core onco-immunological biomarker of cuproptosis and mediates the cross-talk between VEGF and CD99 signaling in glioblastoma

(2023) Yujie Zhou et al.   Journal of Translational Medicine

Immunology and immunotherapy of cholangiocarcinoma

(2023) Tim F. Greten et al.   Nature Reviews Gastroenterology & Hepatology

Mixed Hepatocellular Cholangiocarcinoma: A Comparison of Survival between Mixed Tumors, Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma from a Single Center

(2023) Lea Penzkofer et al.   Cancers

Cuproptosis Induced by ROS Responsive Nanoparticles with Elesclomol and Copper Combined with αPD‐L1 for Enhanced Cancer Immunotherapy

(2023) Boda Guo et al.   ADVANCED MATERIALS

USP51/PD‐L1/ITGB1‐deployed juxtacrine interaction plays a cell‐intrinsic role in promoting chemoresistant phenotypes in non‐small cell lung cancer

(2023) Jianjun Li et al.   Cancer Communications

Cancer statistics, 2022

(2022) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Combination strategies with PD-1/PD-L1 blockade: current advances and future directions

(2022) Ming Yi et al.   Molecular Cancer

Copper induces cell death by targeting lipoylated TCA cycle proteins

(2022) Peter Tsvetkov et al.   SCIENCE

Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians

(2022) Dimitrios Moris et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research

(2022) Xuhui Tong et al.   Journal of Hematology & Oncology

Multiregional single-cell dissection of tumor and immune cells reveals stable lock-and-key features in liver cancer

(2022) Lichun Ma et al.   Nature Communications

Construction of TME and Identification of crosstalk between malignant cells and macrophages by SPP1 in hepatocellular carcinoma

(2021) Lulu Liu et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Comparison of Clinical Features and Outcomes between Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in the United States

(2021) Yi‐Te Lee et al.   HEPATOLOGY

Single-cell atlas of tumor cell evolution in response to therapy in hepatocellular carcinoma and intrahepatic cholangiocarcinoma

(2021) Lichun Ma et al.   JOURNAL OF HEPATOLOGY

Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma

(2021) Liangqing Dong et al.   CANCER CELL

Eicosanoid regulation of debris-stimulated metastasis

(2021) Jianjun Deng et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Liver resection and transplantation for intrahepatic cholangiocarcinoma

(2020) Vincenzo Mazzaferro et al.   JOURNAL OF HEPATOLOGY

CellPhoneDB: inferring cell–cell communication from combined expression of multi-subunit ligand–receptor complexes

(2020) Mirjana Efremova et al.   Nature Protocols

Elesclomol alleviates Menkes pathology and mortality by escorting Cu to cuproenzymes in mice

(2020) Liam M. Guthrie et al.   SCIENCE

A Phase 2 Multi-institutional Study of Nivolumab for Patients With Advanced Refractory Biliary Tract Cancer

(2020) Richard D. Kim et al.   JAMA Oncology

EP4 signalling is essential for controlling islet inflammation by causing a shift in macrophage polarization in obesity/type 2 diabetes

(2020) Mika Yasui-Kato et al.   Diabetes & Vascular Disease Research

Ferroptosis, necroptosis, and pyroptosis in anticancer immunity

(2020) Rong Tang et al.   Journal of Hematology & Oncology

PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis

(2020) Junwei Hou et al.   NATURE CELL BIOLOGY

Retinoic acid-related orphan receptor C regulates proliferation, glycolysis, and chemoresistance via the PD-L1/ITGB6/STAT3 signaling axis in bladder cancer

(2019) Dalong Cao et al.   CANCER RESEARCH

PD-L1 (B7-H1) Competes with the RNA Exosome to Regulate the DNA Damage Response and Can Be Targeted to Sensitize to Radiation or Chemotherapy

(2019) Xinyi Tu et al.   MOLECULAR CELL

Mitochondrial metabolism promotes adaptation to proteotoxic stress

(2019) Peter Tsvetkov et al.   Nature Chemical Biology

A global view of hepatocellular carcinoma: trends, risk, prevention and management

(2019) Ju Dong Yang et al.   Nature Reviews Gastroenterology & Hepatology

Nivolumab alone or in combination with cisplatin plus gemcitabine in Japanese patients with unresectable or recurrent biliary tract cancer: a non-randomised, multicentre, open-label, phase 1 study

(2019) Makoto Ueno et al.   Lancet Gastroenterology & Hepatology

Mechanisms Controlling PD-L1 Expression in Cancer

(2019) Jong-Ho Cha et al.   MOLECULAR CELL

Identification of four immune subtypes characterized by distinct composition and functions of tumor microenvironment in intrahepatic cholangiocarcinoma

(2019) Sylvie Job et al.   HEPATOLOGY

Diagnosis, Staging and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases

(2018) Jorge A. Marrero et al.   HEPATOLOGY

Integrating single-cell transcriptomic data across different conditions, technologies, and species

(2018) Andrew Butler et al.   NATURE BIOTECHNOLOGY

Programmed death ligand 1 promotes lymph node metastasis and glucose metabolism in cervical cancer by activating integrin β4/SNAI1/SIRT3 signaling pathway

(2018) Shaojia Wang et al.   ONCOGENE

Cohort contributions to trends in the incidence and mortality of intrahepatic cholangiocarcinoma

(2018) Eliza W. Beal et al.   HEPATOBILIARY SURGERY AND NUTRITION

Single-cell reconstruction of the early maternal–fetal interface in humans

(2018) Roser Vento-Tormo et al.   NATURE

Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma

(2016) Nestor F. Esnaola et al.   CANCER

Intrahepatic cholangiocarcinoma: Epidemiology, risk factors, diagnosis and surgical management

(2016) Han Zhang et al.   CANCER LETTERS

Apoptosis, autophagy, necroptosis, and cancer metastasis

(2015) Zhenyi Su et al.   Molecular Cancer

Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma

(2014) John Bridgewater et al.   JOURNAL OF HEPATOLOGY

Treatment and Prognosis for Patients With Intrahepatic Cholangiocarcinoma

(2014) Michael N. Mavros et al.   JAMA Surgery

Copper: An essential metal in biology

(2011) Richard A. Festa et al.   CURRENT BIOLOGY

Genomic and Genetic Characterization of Cholangiocarcinoma Identifies Therapeutic Targets for Tyrosine Kinase Inhibitors

(2011) Jesper B. Andersen et al.   GASTROENTEROLOGY

ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking

(2010) Matthew D. Wilkerson et al.   BIOINFORMATICS

Copper handling machinery of the brain

(2010) Svetlana Lutsenko et al.   Metallomics

Copper Homeostasis: The Role of Cellular Transporters

(2010) Edward D. Harris   NUTRITION REVIEWS

Diagnosis and treatment of Wilson disease: An update

(2008) Eve A. Roberts et al.   HEPATOLOGY